Legato Capital Management LLC
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1442641
San Francisco, CA
Position in NAMS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$690,455
-$2,250,406 QoQ
Shares Held
21,570
-74.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $23,431,924 across 9 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
58,512 | $6,849,999 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
23,490 | $3,589,741 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
41,186 | $3,581,122 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
8,713 | $3,238,360 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
26,046 | $2,538,964 | |
| 6 | INSM |
INSMED Inc
|
11,129 | $1,186,573 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
8,354 | $957,953 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
21,409 | $779,501 |
All Filings in NAMS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $690,455 | 21,570 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $2,940,861 | 83,833 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $664,642 | 23,370 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $340,268 | 18,789 | Shares | Other | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||